Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease

Main Article Content

Sergio Caravita*
Ilaria Tanini
Lia Crotti
Claudia Baratto
Gianfranco Parati
Francesco Fattirolli
Iacopo Olivotto
Franco Cecchi

Downloads

Download data is not yet available.

Article Details

Caravita, S., Tanini, I., Crotti, L., Baratto, C., Parati, G., Fattirolli, F., Olivotto, I., & Cecchi, F. (2021). Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease. Journal of Cardiovascular Medicine and Cardiology, 8(4), 069–071. https://doi.org/10.17352/2455-2976.000173
Short Communications

Copyright (c) 2021 Caravita S, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Nagueh SF (2014) Anderson-Fabry disease and other lysosomal storage disorders. Circulation 130: 1081-1090. Link: https://bit.ly/3mE6Z3e

Spinelli L, Nicolai E, Acampa W, Imbriaco M, Pisani A, et al. (2008) Cardiac performance during exercise in patients with Fabry's disease. Eur J Clin Invest 38: 910-917. Link: https://bit.ly/3q0jc4k

Calcagnino M, O'Mahony C, Coats C, Cardona M, Garcia A, et al. (2011) Exercise-induced left ventricular outflow tract obstruction in symptomatic patients with Anderson-Fabry disease. J Am Coll Cardiol 58: 88-89. Link: https://bit.ly/2ZPZddq

Bierer G, Balfe D, Wilcox WR, Mosenifar Z (2006) Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease. J Inherit Metab Dis 29: 572-579. Link: https://bit.ly/3mEcrD4

Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9: 34-45. Link: https://bit.ly/2ZL8Que

Lobo T, Morgan J, Bjorksten A, Nicholls K, Grigg L, et al. (2008) Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement. Intern Med J 38: 407-414. Link: https://bit.ly/3GLYawk

Patel MR, Cecchi F, Cizmarik M, Kantola I, Linhart A, et al. (2011) Cardiovascular events in patients with Fabry disease natural history data from the Fabry registry. J Am Coll Cardiol 57: 1093-1099. Link: https://bit.ly/2ZMRSLK

Tomberli B, Cecchi F, Sciagrà R, Berti V, Lisi F, et al. (2013) Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. Eur J Heart Fail 15: 1363-1373. Link: https://bit.ly/3k0Gof6

Pichette M, Serri K, Pagé M, Di LZ, Bichet DG, et al. (2017) Impaired Left Atrial Function in Fabry Disease: A Longitudinal Speckle-Tracking Echocardiography Study. J Am Soc Echocardiogr 30: 170-179.e2. Link: https://bit.ly/3GHXxDY

Baratto C, Caravita S, Soranna D, Faini A, Dewachter C, et al. (2021) Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction. Circ Heart Fail 14: e007555. Link: https://bit.ly/3nQ08TD